Finding:

1. close

   Deleted in Colorectal Cancer

   Deleted in Colorectal Carcinoma, also known as DCC, is a protein which in humans is encoded by the DCC gene. ... Deleted in Colorectal Cancer has been shown to interact with PTK2, APPL1, MAZ, Caspase 3, NTN1 and Androgen receptor.
2. close

   Colorectal cancer

   Colorectal cancer, also called colon cancer or large bowel cancer, includes cancerous growths in the colon, rectum and appendix. ... When Wnt binds to a receptor on the cell, that sets in motion a chain of molecular events that ends with β-catenin moving into the nucleus and activating a gene on DNA.
3. close

   Receptor protein serine/threonine kinase

   In enzymology, a receptor protein serine/threonine kinase (EC 2.7.11.30) is an enzyme that catalyzes the chemical reaction ... This enzyme participates in 7 metabolic pathways: mapk signaling pathway, cytokine-cytokine receptor interaction, tgf-beta signaling pathway, adherens junction, colorectal cancer, pancreatic cancer, and chronic myeloid leukemia.
4. close

   Mouse models of colorectal and intestinal cancer

   Mouse models of colorectal cancer and intestinal cancer are experimental systems in which mice are genetically manipulated or challenged with chemicals to develop malignancies in the gastrointestinal tract. ... Yet these adenocarcinomas do not metastasize and their histopathology is similar to that of the right side colon cancer in human with frequent mutation of the type II receptor for TGF-β.
5. close

   Epidermal growth factor receptor

   Epidermal growth factor receptor has been shown to interact with PLCG1, NCK1, Janus kinase 2,... STAT1, CBLC, Src, Androgen receptor, STAT3, GRB14, Grb2, PLSCR1,... ... [Expression error: Missing operand for > "Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer"].
6. close

   Cetuximab

   Cetuximab (IMC-C225—marketed under the name Erbitux) is a chimeric (mouse/human) monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer. ... "FDA updates Vectibix and Erbitux labels with KRAS testing info".
7. close

   Cancer immunotherapy

   | Cetuximab | Erbitux | 2004 | chimeric | epidermal growth factor receptor | colorectal cancer | ... One mechanism in which beta-glucans are able to activate the immune system, is by interacting with the Macrophage-1 antigen (CD18) receptor on immune cells.
8. close

   Androgen receptor

   The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor which is activated by... ... Androgen receptor has been shown to... .. 1, Nuclear receptor coactivator 2,... FHL2, Nuclear receptor co-repressor 1,... D1, Nuclear receptor co-repressor 2,... ... growth factor receptor, Calmodulin 1,... 1,... Deleted in Colorectal Cancer, RCHY1,...
9. close

   Cancer

   One mechanism in which beta-glucans are able to activate the immune system, is by interacting with the Macrophage-1 antigen (CD18) receptor on immune cells. ... [Expression error: Missing operand for > "Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G(2)/M cell cycle arrest"].
10. close

    NTN1

    NTN1 has been shown to interact with Deleted in Colorectal Cancer. ... [Expression error: Missing operand for > "Deleted in Colorectal Cancer (DCC) encodes a netrin receptor."].

Explore the following pages on Powerset:

• Deleted in Colorectal Cancer,
• Colorectal cancer,
• Receptor protein serine/threonine kinase,
• Mouse models of colorectal and intestinal cancer,
• Epidermal growth factor receptor,
• Cetuximab,
• Cancer immunotherapy,
• Androgen receptor,
• Cancer,
• NTN1

Try this on Bing Research

Bing